Auto-SCT for AML in second remission: CALGB Study 9620

Claudia Linker, Kouros Owzar(Duke University), Lloyd E. Damon(University of California, San Francisco), Richard A. Larson(Urbana University), Bayard L. Powell(Atrium Health Wake Forest Baptist), Laura Archer(The Royal Wolverhampton NHS Trust), David D. Hurd(Duke University)

Bone Marrow Transplantation

March 16, 2009

10.1038/bmt.2009.36

Cited by 35

Related Papers

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

|Blood|2016|5.9k

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

|Blood|2009|3.4k

Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

|Blood|2022|3.1k

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

|Blood|2022|2.8k

Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

|Journal of Clinical Oncology|2003|2.7k